1-4 of 4
Peter J Hosein, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II study of 90 y Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Marginal Zone Lymphoma

Jesus C Fabregas, MD, James E. Hoffman, MD, Tulay Koru-Sengul, PhD, Miao Feng, Deborah Goodman, Aldo Serafini, MD, Peter J Hosein, MD, Alexandra Stefanovic, MD, Joseph D. Rosenblatt, MD, Izidore S. Lossos, MD
Journal: Blood
Blood (2014) 124 (21): 1762.
https://doi.org/10.1182/blood.V124.21.1762.1762
Published: 2014
Journal Articles

Updated Analysis of a Prospective Phase II Trial of R-MACLO-IVAM Followed by Maintenance for Mantle Cell Lymphoma

Jose D Sandoval-Sus, MD, Peter J Hosein, MD, Deborah Goodman, BHSC, Alexandra Stefanovic, MD, Joseph D Rosenblatt, MD, Izidore S Lossos, MD
Journal: Blood
Blood (2012) 120 (21): 1622.
https://doi.org/10.1182/blood.V120.21.1622.1622
Published: 2012
Journal Articles

Primary Breast Diffuse Large B Cell Lymphoma: A Distinct Clinical Entity

Matthew P Salzberg, Jocelyn C Maragulia, Oliver W. Press, MD, PhD, Thomas M Habermann, MD, Julie M Vose, MD, MBA, Martin Bast, BS, Ranjana H. Advani, MD, Andrew M. Evens, DO, MSc, Nahida Islam, MD, John P. Leonard, MD, Peter Martin, MD, Peter J Hosein, MD, Andrew D Zelenetz, MD, PhD, Izidore S Lossos, MD
Journal: Blood
Blood (2012) 120 (21): 1618.
https://doi.org/10.1182/blood.V120.21.1618.1618
Published: 2012
Journal Articles

High Remission Rates and Prolonged Progression Free Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma Treated with R-MACLOIVAM-T

Peter J Hosein, MD, Daniel Morgensztern, MD, Francine Coleman, MPH, Gail Walker, PhD, Maricer Escalon, MD, Joseph Rosenblatt, MD, Izidore S Lossos, MD
Journal: Blood
Blood (2008) 112 (11): 3597.
https://doi.org/10.1182/blood.V112.11.3597.3597
Published: 2008